ATE400602T1 - Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen - Google Patents

Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen

Info

Publication number
ATE400602T1
ATE400602T1 AT03800398T AT03800398T ATE400602T1 AT E400602 T1 ATE400602 T1 AT E400602T1 AT 03800398 T AT03800398 T AT 03800398T AT 03800398 T AT03800398 T AT 03800398T AT E400602 T1 ATE400602 T1 AT E400602T1
Authority
AT
Austria
Prior art keywords
thiosulfonate
compositions
hydrogels
forming
hydrogel
Prior art date
Application number
AT03800398T
Other languages
English (en)
Inventor
Michael Bentley
Zhihao Fang
Original Assignee
Nektar Therapeutics Al Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics Al Corp filed Critical Nektar Therapeutics Al Corp
Application granted granted Critical
Publication of ATE400602T1 publication Critical patent/ATE400602T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
    • C08G65/3342—Polymers modified by chemical after-treatment with organic compounds containing sulfur having sulfur bound to carbon and hydrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00—Characterised by the use of unspecified polymers
    • C08J2300/14—Water soluble or water swellable polymers, e.g. aqueous gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2381/00—Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing sulfur with or without nitrogen, oxygen, or carbon only; Polysulfones; Derivatives of such polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Polyethers (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03800398T 2002-12-31 2003-12-31 Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen ATE400602T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43725202P 2002-12-31 2002-12-31

Publications (1)

Publication Number Publication Date
ATE400602T1 true ATE400602T1 (de) 2008-07-15

Family

ID=32713157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03800398T ATE400602T1 (de) 2002-12-31 2003-12-31 Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen

Country Status (6)

Country Link
US (5) US7312301B2 (de)
EP (1) EP1578843B1 (de)
AT (1) ATE400602T1 (de)
AU (1) AU2003300140A1 (de)
DE (1) DE60322111D1 (de)
WO (1) WO2004060967A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE400602T1 (de) 2002-12-31 2008-07-15 Nektar Therapeutics Al Corp Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen
EP1596887B1 (de) 2003-02-26 2022-03-23 Nektar Therapeutics Polymer-factor viii-konjugate
EP1617872A4 (de) * 2003-04-10 2011-09-07 3M Innovative Properties Co Verfahren und zusammensetzungen zur verbesserung der immunantwort
CA2521682A1 (en) * 2003-04-10 2004-12-16 3M Innovative Properties Company Delivery of immune response modifier compounds using metal-containing particulate support materials
JP4805911B2 (ja) * 2004-03-15 2011-11-02 ネクター セラピューティクス Ｈｉｖ侵入阻害剤のポリマー系組成物及び複合体
US8303973B2 (en) * 2004-09-17 2012-11-06 Angiotech Pharmaceuticals (Us), Inc. Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
US20070060658A1 (en) * 2005-08-31 2007-03-15 Diaz David D Stabilization of organogels and hydrogels by azide-alkyne [3+2] cycloaddition
EP1968644B1 (de) 2005-12-16 2012-06-27 Nektar Therapeutics Polymerkonjugate von glp-1
US7462627B2 (en) 2006-02-09 2008-12-09 Enzon Pharmaceuticals, Inc. Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
US7671067B2 (en) 2006-02-09 2010-03-02 Enzon Pharmaceuticals, Inc. Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin
CN101500623B (zh) 2006-06-15 2016-08-24 微温森公司 一种由可膨胀聚合物构成的栓塞器械
EP1891941A1 (de) * 2006-08-11 2008-02-27 OctoPlus Technologies B.V. Wässrige Gele enthaltend Mikrokügelchen
BRPI0807232A2 (pt) 2007-02-09 2014-04-29 Enzon Pharmaceuticals Inc Tratamento de cânceres resistentes ou refratários com conjugados poliméricos multi-braços de 7-etil-10-hidroxicamptotecina
US20080287633A1 (en) * 2007-05-18 2008-11-20 Drumheller Paul D Hydrogel Materials
US8067028B2 (en) * 2007-08-13 2011-11-29 Confluent Surgical Inc. Drug delivery device
CA2709379C (en) 2007-12-21 2016-08-16 Microvention, Inc. Hydrogel filaments for biomedical uses
US20100112014A1 (en) * 2008-04-11 2010-05-06 Gilbert Ryan J Novel hydrogel compositions and methods of using
US10799593B2 (en) 2008-06-09 2020-10-13 Northwestern University Nanodiamond particle complexes
US20100040672A1 (en) * 2008-06-09 2010-02-18 Northwestern University Delivery of therapeutics
MX2011001583A (es) 2008-08-11 2011-04-04 Nektar Therapeutics Conjugados de alcanoato polimericos de multiples brazos.
US8443146B2 (en) * 2008-09-18 2013-05-14 International Business Machines Corporation Techniques for cache injection in a processor system responsive to a specific instruction sequence
US8429349B2 (en) * 2008-09-18 2013-04-23 International Business Machines Corporation Techniques for cache injection in a processor system with replacement policy position modification
CA2777171C (en) 2009-10-26 2017-09-19 Microvention, Inc. Embolization device constructed from expansile polymer
WO2011065916A1 (en) * 2009-11-24 2011-06-03 Agency For Science, Technology And Research Crosslinking branched molecule through thiol-disulfide exchange to form hydrogel
US8524215B2 (en) * 2010-08-02 2013-09-03 Janssen Biotech, Inc. Absorbable PEG-based hydrogels
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
SG11201400444VA (en) * 2011-09-07 2014-04-28 Prolynx Llc Hydrogels with biodegradable crosslinking
US9011884B2 (en) 2012-04-18 2015-04-21 Microvention, Inc. Embolic devices
CN104363922B (zh) 2012-06-14 2017-06-30 微仙美国有限公司 聚合物治疗组合物
CA2870170C (en) 2012-09-12 2018-06-12 Boston Scientific Scimed, Inc. Adhesive stent coating for anti-migration
WO2014059446A1 (en) * 2012-10-12 2014-04-17 Case Western Reserve University Biodegradable hydrogel for polynucleotide delivery
BR112015008245B1 (pt) 2012-10-15 2022-09-27 Microvention, Inc Composições poliméricas de tratamento
EP3030278B1 (de) 2013-08-08 2018-09-19 Boston Scientific Scimed, Inc. Stent mit löslichem oder abbaubarem klebstoffpolymer zur verhinderung einer migration
US10173375B2 (en) 2014-03-05 2019-01-08 Bacterin International, Inc. Shaped fiber-based products and method of manufacture thereof
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
US10226533B2 (en) 2014-04-29 2019-03-12 Microvention, Inc. Polymer filaments including pharmaceutical agents and delivering same
US11046828B2 (en) * 2015-04-21 2021-06-29 Trustees Of Tufts College Fabrication of macroporous monodisperse hydrogel microspheres
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation
US10821004B2 (en) * 2015-06-30 2020-11-03 Bacterin Interational, Inc. Expandable bone grafts and methods of manufacture thereof
US10368874B2 (en) 2016-08-26 2019-08-06 Microvention, Inc. Embolic compositions
CN107602432B (zh) * 2017-10-01 2019-06-07 刘云晖 一种可溶性水凝胶用交联剂及其制备方法和应用
US10576182B2 (en) 2017-10-09 2020-03-03 Microvention, Inc. Radioactive liquid embolic
CN111388748B (zh) * 2020-03-03 2021-08-06 东华大学 一种抗菌止血多功能复合水凝胶敷料及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE598976A (de) * 1960-01-11
DE1223156B (de) * 1961-05-27 1966-08-18 Hoechst Ag Verfahren zur Herstellung von hoehermolekularen Polykondensaten
CS159361B1 (de) * 1970-09-08 1975-01-31
IE49097B1 (en) * 1978-11-10 1985-07-24 Ic Gas Int Ltd Thermal energy storage material
AU537741B2 (en) * 1979-03-21 1984-07-12 British Technology Group Limited Controlled release compositions
JPS60114584A (ja) * 1983-11-25 1985-06-21 Otsuka Chem Co Ltd チオスルホナ−ト誘導体の製造法
JP2664153B2 (ja) * 1987-06-05 1997-10-15 富士写真フイルム株式会社 ハロゲン化銀カラー写真感光材料およびその現像処理方法
US4983579A (en) * 1988-11-18 1991-01-08 International Flavors & Fragrances Inc. Cyano-substituted sulfur containing compounds, compositions containing same, processes for preparing same and organoleptic uses thereof
DE4014537A1 (de) * 1990-05-07 1991-11-14 Goldschmidt Ag Th Verfahren zur herstellung von hochelastischen, polyurethangruppen aufweisenden schaumstoffen mit verminderter stauchhaerte
US5393798A (en) * 1992-06-05 1995-02-28 Spenco Medical Corporation Hydrogel material and method of preparation
DE69315213T2 (de) 1992-07-06 1998-03-19 Biomira Inc Photoaktivierung von proteinen zu konjugationszwecken
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
PT1061954E (pt) 1998-03-12 2004-10-29 Nektar Therapeutics Al Corp Derivados de poli(etileno glicol) com grupos reactivos proximos
DE69939538D1 (de) * 1998-07-02 2008-10-23 Univ Toronto Mit einer kohlenhydratgruppe chemisch modifizierte proteine
US6131274A (en) * 1999-07-01 2000-10-17 3Com Corporation Apparatus and method for guiding a circuit board into an electronic chassis
JP4344110B2 (ja) 1999-10-08 2009-10-14 ネクター セラピューティックス エイエル，コーポレイション ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
GB2374072B (en) * 2000-06-16 2004-09-22 Nippon Catalytic Chem Ind Crosslinked polymer method for manufacturing it and use thereof
JP2002049123A (ja) * 2000-08-04 2002-02-15 Fuji Photo Film Co Ltd 熱現像感光材料および画像形成方法
AU2001293581A1 (en) * 2000-09-26 2002-04-08 Neurortho Implants Design, Llc Inter-vertebral disc prosthesis for lumbar rachis through posterior surgery thereof
US7053150B2 (en) * 2000-12-18 2006-05-30 Nektar Therapeutics Al, Corporation Segmented polymers and their conjugates
TW593427B (en) * 2000-12-18 2004-06-21 Nektar Therapeutics Al Corp Synthesis of high molecular weight non-peptidic polymer derivatives
ATE400602T1 (de) 2002-12-31 2008-07-15 Nektar Therapeutics Al Corp Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen

Also Published As

Publication number Publication date
US20120289609A1 (en) 2012-11-15
DE60322111D1 (de) 2008-08-21
US8097695B2 (en) 2012-01-17
US20050143484A1 (en) 2005-06-30
EP1578843A1 (de) 2005-09-28
US20100004424A1 (en) 2010-01-07
AU2003300140A1 (en) 2004-07-29
US7312301B2 (en) 2007-12-25
US20080033105A1 (en) 2008-02-07
US8450390B2 (en) 2013-05-28
WO2004060967A1 (en) 2004-07-22
EP1578843B1 (de) 2008-07-09
US7598338B2 (en) 2009-10-06
US20120088927A1 (en) 2012-04-12
US8247598B2 (en) 2012-08-21

Similar Documents

Publication Publication Date Title
ATE400602T1 (de) Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen
DE60314865D1 (de) Verfahren zur herstellung von modifiziertem polymer, danach erhaltenes modifiziertes polymer und kautschukzusammensetzung
DE50309432D1 (de) Verfahren zur herstellung von wässrigen dispersionen
DE60222741D1 (de) Verfahren zur herstellung von beschichteter polymerfolie
NO20063147L (no) Antivirale farmasoytiske blandinger
ATE427342T1 (de) Modifizierte pigmente, ein verfahren zur herstellung von modifizierten pigmenten und sie enthaltende tintenzusammensetzungen
AR038563A1 (es) Composicion de ziprasidona y controles sinteticos
DE60219197D1 (de) Verfahren zur herstellung von lösungen oder dispersionen von polythiophenepolymeren
ATE547101T1 (de) Verfahren zur verwendung von diketopiperazinen und zusammensetzungen, die diese enthalten
DE602005023529D1 (de) Homogener nachweis von analyten
ATE370981T1 (de) Verfahren zur herstellung von gut in wasser redispergierbaren polymerisatpulvern
EA200600440A1 (ru) 4-((феноксиалкил)тио)еноксиуксусные кислоты и их аналоги
TW200643622A (en) Antireflective hardmask composition and methods for using same
PT1560812E (pt) Compostos de aminociclohexil eter e suas utilizacoes
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
ATE435874T1 (de) Chemische zusammensetzung und verfahren
NO20072880L (no) Injiserbar vetrinaerblanding
ATE309283T1 (de) Wässrige dispersion und ihre verwendung zur herstellung von thermisch und mit aktinischer strahlung härtbaren beschichtungsstoffen, klebstoffen und dichtmassen
ATE322826T1 (de) Verfahren zur herstellung von pastenextrudierten sulfonamidzusammensetzungen
DE69821376D1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
ATE326437T1 (de) Beschichtungszusammensetzung, insbesondere für glasoberflächen, und verfahren zu deren herstellung und verwendung
DE60326022D1 (de) Verfahren zur Herstellung von leitfähigen thermoplastischen Zusammensetzungen
DE50301594D1 (de) Verfahren zur Herstellung von Emulsionspolymeren mit hoher Reinheit
DE60228400D1 (de) Verfahren zur Herstellung von modifiziertem Polymerkautschuk
DE60329907D1 (de) Verfahren zur herstellung von wasserlöslichem carboxyliertem polymer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties